Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, multicenter, placebo-controlled, parallel study to evaluate the
efficacy and safety of Tolvaptan in the treatment of patients with cardiac edema (body fluid
retention caused by congestive heart failure) based on the conventional therapy.
To evaluate the efficacy and safety of Tolvaptan 15 mg on congestive heart failure patients
with body fluid retention after current diuretic treatment, after continuous treatment of 7
days' oral Tolvaptan 15mg or placebo.